Wei Zhou | Biomedicine | Best Researcher Award

Dr. Wei Zhou | Biomedicine | Best Researcher Award 

Dr. Wei Zhou, Shenzhen University, China

Dr. Wei Zhou, an Associate Research Fellow at Shenzhen University, specializes in traditional Chinese medicine systems pharmacology, bioinformatics, and systems biology. A Shenzhen High-Level Talent, she has published 34 SCI papers and led six national and provincial research projects. With an SCI citation index of 5085 and an H-index of 15, her work advances interdisciplinary research in TCM modernization. She has applied for five patents and serves as a Council Member of the China Association of Traditional Chinese Medicine Information. Her research focuses on developing low-side-effect drugs and novel disease treatment mechanisms through integrated systems pharmacology approaches.

Early Academic Pursuits 🎓

Wei Zhou’s journey into academia began with a strong foundation in bioinformatics, culminating in a Ph.D. in the field. Her passion for integrative medicine led her to pursue postdoctoral research in Basic Integrative Medicine, where she developed a unique interdisciplinary perspective. Her academic endeavors were driven by an ambition to merge traditional Chinese medicine (TCM) with modern scientific methodologies. As a dedicated scholar, she demonstrated early promise, excelling in both theoretical and applied research.

Professional Endeavors 🏛️

Currently serving as an Associate Research Fellow at the Faculty of Medicine, Shenzhen University, Wei Zhou has established herself as a key figure in bioinformatics and systems biology. Her expertise in traditional Chinese medicine systems pharmacology has positioned her at the forefront of TCM modernization. As a recognized Shenzhen High-Level Talent, she has contributed significantly to national, provincial, and municipal research projects, leading six major research initiatives.

Contributions and Research Focus 🔬

Wei Zhou’s research primarily focuses on integrating systems pharmacology approaches with bioinformatics to explore TCM’s pharmacodynamic properties, molecular targets, and therapeutic mechanisms. Through her extensive work, she has developed novel methodologies for analyzing the complex interactions between TCM and the human body. Her contributions include:

  • Development of TCM-based interventions for disease treatment using signaling pathway analysis.
  • Discovery of new drug targets and low-side-effect TCM-derived molecules, providing alternatives to conventional pharmaceutical approaches.
  • Bridging the gap between traditional medicine and modern computational biology, thereby fostering interdisciplinary collaboration in biomedical research.

Her work is substantiated by the publication of 34 SCI-indexed journal articles, demonstrating her research’s depth and impact. With an H-index of 15 and over 5085 citations, her studies have gained significant recognition within the scientific community.

Accolades and Recognition 🏆

Throughout her career, Wei Zhou has earned prestigious accolades, cementing her reputation as a distinguished researcher. Her contributions to traditional Chinese medicine information systems have been acknowledged through her role as a Council Member of the China Association of Traditional Chinese Medicine Information. Furthermore, her achievements in innovation and academic excellence have led to the application of five patents, reinforcing her standing in biomedical research and pharmacology.

Impact and Influence 🌍

Wei Zhou’s research has had a profound impact on both academia and the healthcare industry. Her interdisciplinary approach has not only advanced scientific understanding but also provided practical applications for TCM in modern medicine. By leveraging computational techniques, she has improved the accuracy of drug-target predictions and therapeutic mechanisms, which has the potential to revolutionize how traditional medicine is integrated into clinical practice. Her work has also inspired young scholars and researchers to pursue interdisciplinary studies, bridging the gap between ancient medical traditions and contemporary scientific research.

Legacy and Future Contributions 🚀

Looking ahead, Wei Zhou aims to further expand her research in vector control, applied pharmacology, and integrative medicine. She envisions a future where bioinformatics and AI-driven technologies will play a pivotal role in TCM research, offering precision-based solutions for complex diseases. Her dedication to innovation and research excellence ensures that her contributions will continue to shape the landscape of traditional medicine modernization.

With a strong commitment to interdisciplinary collaboration, she aspires to lead projects that enhance the global recognition of TCM as a scientifically validated and effective healthcare approach. Her ongoing efforts in patent development and pharmacological studies are expected to drive new breakthroughs, ultimately contributing to the broader field of medical research.

Through her research, Wei Zhou has not only pushed the boundaries of bioinformatics and pharmacology but also fostered a greater appreciation for the potential of TCM in global healthcare systems. As she continues her work, her impact will undoubtedly resonate across academic and medical communities worldwide.

Publications Top Notes

An empirical study of multifactorial PSO and multifactorial DE

Author: L Feng, W Zhou, L Zhou, SW Jiang, JH Zhong, BS Da, ZX Zhu, Y Wang
Journal: IEEE Congress on evolutionary computation
Year: 2017
Author: L Feng, W Zhou, W Liu, YS Ong, KC Tan
Journal: IEEE Transactions on Cybernetics
Year:2020
Author: W Zhou, L Feng, KC Tan, M Jiang, Y Liu
Journal: Transactions on Evolutionary Computation
Year: 2021

Zahra Gholi | Health Professions | Best Paper Award

Dr. Zahra Gholi | Health Professions | Best Paper Award

Researcher at Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran

Dr. Zahra Gholi is a distinguished health researcher affiliated with the Minimally Invasive Surgery Research Center at Iran University of Medical Sciences. With a Ph.D. in nutrition sciences from Shahid Beheshti Medical Sciences, her expertise spans nutritional assessment, statistical analysis, and research methodology, particularly focusing on critically ill and bariatric surgery patients. Dr. Gholi has published several impactful articles and actively contributes to the radio program “Food, Health, Life.” Her research is recognized for its practical applications in improving patient care, and she is a member of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). 🌟🔬📊

Professional Profiles:

🎓 Education

Dr. Zahra Gholi completed her PhD in Nutrition Sciences at Shahid Beheshti University of Medical Sciences, one of Iran’s premier institutions. Her dissertation, titled “Examining the Nutritional Status of Critically Ill Elderly COVID-19 Patients Admitted to the Intensive Care Unit,” earned an A score and was completed in 2022. This work led to the publication of several influential articles in the field. 🩺🎓📚

Professional Experience

Dr. Zahra Gholi is a dedicated health researcher at the Minimally Invasive Surgery Research Center, Iran University of Medical Sciences. She has conducted numerous research projects, with a particular focus on nutrition and bariatric surgery. Dr. Gholi has completed 12 research projects and is currently working on four ongoing studies. She is also involved in public outreach, participating as an expert in the radio program “Food, Health, Life.” Her contributions to the field are reflected in her publications and her active role in advancing nutrition science in critically ill and bariatric surgery patients. 🥼🔬📡

Research Interest

Dr. Zahra Gholi’s research interests are primarily focused on nutrition and its impact on health, particularly in the context of bariatric surgery, vitamin D, and chronic diseases. She is deeply involved in examining the nutritional status of critically ill patients, including elderly COVID-19 patients admitted to intensive care units. Her work aims to improve dietary patterns and nutritional interventions for patients undergoing bariatric surgery, with a goal to localize these practices in Iran. Dr. Gholi is passionate about exploring the connections between nutrition and chronic disease management to enhance patient outcomes and overall health. 🍏🩺🔬

Award and Honors

Dr. Zahra Gholi has been recognized for her outstanding contributions in the field of nutrition sciences. She received the Outstanding Researcher Award from Shahid Beheshti University of Medical Sciences for her exceptional research on the nutritional status of critically ill patients in 2022. Her work on dietary patterns for bariatric surgery patients earned her the Best Paper Award. Additionally, Dr. Gholi was honored with the Excellence in Health Communication Award for her expert participation in the radio program “Food, Health, Life,” where she shares valuable insights on nutrition and health with the public. These accolades underscore her dedication to advancing nutrition science and improving patient care through innovative research and effective communication. 🏆📚🎉

Research Skills

Dr. Zahra Gholi possesses a robust set of research skills pivotal to her field of nutrition sciences. She excels in nutritional assessment, employing advanced methodologies to evaluate the dietary needs of critically ill and bariatric surgery patients. Her expertise in statistical analysis enables her to interpret complex data accurately, ensuring her research findings are both reliable and impactful. Dr. Gholi is proficient in research design and methodology, which allows her to conduct rigorous studies that contribute significantly to her field. Additionally, her skills in scientific writing are evident from her numerous publications in reputable journals. She is also adept at collaborative research, often working with multidisciplinary teams to enhance the scope and application of her studies. 🌟🔬📊

Publications

  1. The characteristics of pre-diabetic patients associated with body composition and cardiovascular disease risk factors in the Iranian population
    Authors: Z Gholi, M Heidari-Beni, A Feizi, B Iraj, G Askari
    Journal: Journal of Research in Medical Sciences
    Year: 2016
    Citations: 28
  2. The effect of synbiotic supplementation on body composition and lipid profile in patients with NAFLD: a randomized, double-blind, placebo-controlled clinical trial study
    Authors: A Asgharian, V Mohammadi, Z Gholi, A Esmaillzadeh, A Feizi
    Journal: Iranian Red Crescent Medical Journal (IRCMJ)
    Year: 2017
    Citations: 26
  3. Fruit and vegetable intake, body mass index and waist circumference among young female students in Isfahan
    Authors: RS Ghalaeh, Z Gholi, SS Bank, L Azadbakht
    Journal: Journal of Education and Health Promotion
    Year: 2012
    Citations: 21
  4. Vitamin D deficiency is associated with increased risk of delirium and mortality among critically ill, elderly COVID-19 patients
    Authors: Z Gholi, D Yadegarynia, H Eini-Zinab, ZV Shariatpanahi
    Journal: Complementary Therapies in Medicine
    Year: 2022
    Citations: 11
  5. Evaluating the relationship between attitudes and beliefs, influencing fast-food eating among students of Hamadan University of Medical Sciences
    Authors: M Barati, A Yarmohammadi, S Mostafaei, Z Gholi, S Razani, SSM Hazave
    Journal: Journal of Health System Research
    Year: 2014
    Citations: 11
  6. The effect of vitamins B on improving the symptoms of migraine: An overview
    Authors: S Nematgorgani, Z Gholi, S Razeghi Jahromi, M Togha, F Karimzadeh
    Journal: Neurosci J Shefaye Khatam
    Year: 2020
    Citations: 7
  7. Fruit and vegetable intake associated with body mass index and waist circumference in young female students
    Authors: R Seyed Ghalaeh, Z Gholi, S Saraf Bank, L Azadbakht
    Journal: Journal of Health System Research
    Year: 2011
    Citations: 7
  8. Nitrite assessment in highly used processed meat products in growing age group in Isfahan city
    Authors: A Yarmohammadi, M Mirlohi, Z Paknahad, Z Gholi
    Journal: International Journal of Environmental Health Engineering
    Year: 2015
    Citations: 2
  9. Associations of body mass index with severe outcomes of COVID-19 among critically ill elderly patients: A prospective study
    Authors: Z Gholi, Z Vahdat Shariatpanahi, D Yadegarynia, H Eini-Zinab
    Journal: Frontiers in Nutrition
    Year: 2023
    Citations: 1
  10. Long-term Systemic Effects of Metabolic Bariatric Surgery: A Multidisciplinary Perspective
    Authors: MR Rajabi, M Rezaei, Z Gholi, S Mokhber, G Mohammadi-Farsani
    Journal: Heliyon
    Year: 2024

 

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease

 

 

Leila Goharian | Nursing and Health Professions | Best Researcher Award

Leila Goharian | Nursing and Health Professions | Best Researcher Award

Ms Leila Goharian, Vancouver Coastal Health Authority, Canada

Leila Goharian is an experienced clinical dietitian with 26 years in the field 🌿. She holds an MSc in Human Services and Healthcare Administration from Capella University and is a Certified Diabetes Educator 🎓. Registered with the College of Dietitians of British Columbia and the American Dietetic Association, she specializes in malnutrition and nutrition support 🏥. As a Dietitian Practice Leader at VCH, she ensures quality patient care, sets practice standards, and mentors students 🌟. Leila’s research focuses on malnutrition and its impact on hospital readmissions, with several publications in reputable journals 📚.

Publication profile

Scopus

Education

With a B.Sc. in Dietetics from the University of British Columbia (May 1997) 🎓, and completing a Dietetic Internship Program in Victoria, BC (July 1998) 🏥, I became a Registered Member of the American Dietetic Association in March 1999 📜. I further enhanced my credentials by passing the CNSD (Certification Examination for Nutrition Support Dietitians) in April 2000 🥼. I earned a Master of Science in Human Services and Healthcare Administration from Capella University in December 2010 🎓. I became a Certified Diabetes Educator on July 1, 2014, reinforcing my commitment to healthcare and nutrition education .

Experience

Since June 2022, serving as VCH Dietitian Practice Leader, advising on regulations and standards, ensuring quality patient care, and leading research initiatives 🩺📚. Previously, Regional Dietitian Educator (Oct 2021-June 2022), leading student programs and RD education strategies 📘🎓. As Community RD (April 2012-Oct 2021), developed a malnutrition screening program 🌱🏥. Worked at Copeman Healthcare Center (2013-2018) and VCH Diabetes Education Center (2012-2013) 🍎🏋️. In Dubai (2010-2011) and BCCA (2009), provided outpatient nutrition counseling 🌍🩺. At King Faisal Hospital (2000-2008), provided ICU nutrition support and advised the Royal Family 🤴🏥. Started at St. Paul’s Hospital (2000) providing ICU nutrition support 🏥.

Certification

📅 Since 2020, I’ve actively pursued leadership and diversity training. I completed the Frontline Leadership Program in December 2022 and the Leadership Conflict Conversation in September 2023. 📈 I explored unconscious bias in April 2022 and anti-racism foundations in March 2022. 📚 My educational journey includes VCH Educator Pathway Levels 1&2 (March 2022) and Level 3 (in progress). I honed my coaching skills in December 2021 and expanded my leadership communication in November 2021. 🌟 Other key achievements include diversity competency modules (August 2021) and certification in ethical research conduct (January 2020). 🚀 These experiences have significantly enhanced my leadership capabilities.

Research focus

L. Goharian’s research focuses on the prevalence and impact of malnutrition in adults receiving home and ambulatory care. The study examines how malnutrition influences 30-day hospital readmission rates. Another area of interest is developing consensus-based nutrition care pathways to facilitate hospital-to-community transitions, particularly for older adults in primary and community care settings. This work aims to improve nutritional outcomes and reduce readmission rates through better nutrition management and care coordination. 🏥🍎📊

Publication top notes

Prevalence of malnutrition and impact on 30-day hospital readmission in adults receiving home care and ambulatory care: A descriptive cohort study

Consensus-based nutrition care pathways for hospital-to-community transitions and older adults in primary and community care

 

 

 

Matheus Sewastjanow-Silva | Health Sciences | Best Researcher Award

Dr. Matheus Sewastjanow-Silva | Health Sciences | Best Researcher Award

Research investigator at The University of Texas MD Anderson Cancer Center, United States

Matheus Sewastjanow da Silva is a Research Investigator at the University of Texas MD Anderson Cancer Center, focusing on clinical studies databases and manuscript analysis. Previously, he worked in Jaffer Ajani’s lab and was a General Practitioner in Brazil, providing emergency and outpatient care. He holds an M.D. from the Federal University of Minas Gerais (UFMG), with internships in various medical specialties at institutions like A.C. Camargo Cancer Center and Jackson Memorial Hospital. Matheus has extensive research experience in surgery and immunology and has actively participated in volunteer medical campaigns and student leadership roles.

Professional Profiles:

🎓 Education

Matheus Sewastjanow da Silva, M.D., earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine in Brazil (2012-2018). His education included additional internships at prominent institutions. He completed a rural outpatient care internship in Esmeraldas, Brazil, and specialized training in Otolaryngology – Head & Neck Surgery at A.C. Camargo Cancer Center, São Paulo, and in Skin, Head & Neck, and Micro/Reconstructive Surgery at Barretos Cancer Hospital. Dr. da Silva also trained in Transplant Surgery and Mohs Micrographic Surgery at the University of Miami. His education was supplemented by various courses, including Pediatric Advanced Life Support (PALS), Advanced Cardiovascular Life Support (ACLS), clinical emergencies, and advanced dermatological surgery. Additionally, he completed courses in clinical therapeutics, psychosomatic diseases, primary immunodeficiencies, and languages (French and Latin). This diverse and rigorous training underscores his commitment to comprehensive medical education and patient care.

Professional Experience

Dr. Matheus Sewastjanow da Silva is currently a Research Investigator in Shirley Su’s research group at the Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center (07/2024-present). His responsibilities include managing clinical studies/trials databases, analyzing and writing manuscripts, and utilizing tools such as RedCap, Epic/SlicerDicer, Foundry, Universe, and Prometheus. Previously, he worked as a Research Investigator in Jaffer Ajani’s lab at the Department of Gastrointestinal Medical Oncology at the same institution (09/2020-06/2024), where he handled clinical samples, patient enrollment, and various laboratory techniques. Before his roles at MD Anderson, Dr. da Silva served as a Physician/General Practitioner in multiple clinics and hospitals across Brazil, providing both outpatient and emergency care, including treating COVID-19 patients. His roles included positions at Nazare Public Family Medicine Clinic, Private Hospital Santa Helena, Public Hospital Vinte e Cinco de Maio, and several Public Emergency Care Centers. Additionally, he gained research experience as an Assistant at the Federal University of Minas Gerais, contributing to studies in General Surgery and Biochemistry, Cellular, and Molecular Immunology.

Research Interest

Dr. Matheus Sewastjanow da Silva is deeply interested in clinical and translational research, focusing on head and neck surgery, gastrointestinal oncology, and emergency medicine. His current research in Shirley Su’s group at MD Anderson Cancer Center involves filling and maintaining clinical studies and trials databases, as well as analyzing and writing manuscripts. He has extensive experience with advanced tools like RedCap, Epic/SlicerDicer, Foundry, Universe, and Prometheus. Dr. da Silva’s previous research in Jaffer Ajani’s lab involved the collection and processing of clinical samples, patient enrollment, DNA/RNA extraction, cell culture, and various molecular biology techniques such as qPCR, Western Blotting, and viral transfections. His research interests extend to the development of novel therapeutic strategies, biomarker discovery, and improving patient outcomes in oncology. Additionally, he is passionate about medical education and the integration of research findings into clinical practice to enhance healthcare delivery.

Award and Honors

Dr. Matheus Sewastjanow da Silva has been recognized for his outstanding contributions to medicine and research through numerous awards and honors. His notable achievements include multiple grant awards and scholarships from esteemed organizations such as the National Council for Scientific and Technological Development (CNPq) and the Research Support Foundation of the State of Minas Gerais (FAPEMIG). Throughout his academic and professional journey, Dr. da Silva has demonstrated exceptional commitment and excellence in his field, earning accolades for his research work, particularly in biochemistry, cellular and molecular immunology, and oncology. His dedication to advancing medical knowledge and improving patient care has been consistently acknowledged, solidifying his reputation as a distinguished physician and researcher in the medical community.

Research Experience 🔬

  • Research Assistant at UFMG General Surgery Laboratory – Andy Petroianu M.D., PhD (07/2015 – 12/2017)
    Roles: Research design, patient consenting, data collection/analysis, database management, manuscript preparation.
  • Research Assistant at UFMG Biochemistry, Cellular and Molecular Immunology Laboratory II – Dawidson Assis Gomes, Msc, PhD (10/2012 – 07/2015)
    Grant Awards: CNPq, FAPEMIG
    Roles: Lab preparations, rodent handling, tissue processing, DNA/RNA extraction, immunohistochemistry, PCR, ELISA, Western Blotting, flow cytometry, data analysis, manuscript preparation.

Research Skills

Proficient in managing clinical studies and trials databases using RedCap, Epic/SlicerDicer, Foundry, Universe, and Prometheus, I have extensive experience in collecting, processing, and managing clinical samples, including blood, ascites, and tissue. My molecular techniques expertise encompasses DNA/RNA extraction, qPCR, Western Blotting, viral transfections, and immunohistochemistry. Additionally, I am skilled in cell isolation, culture, and viral transfections. I have significant experience in rodent handling and conducting mouse studies. Competent in statistical analysis and data interpretation using various software tools, I am also proficient in writing and reviewing abstracts, articles, manuscripts, posters, and slide presentations. My laboratory skills include preparing buffers, tissue staining, cryostat tissue sectioning, PCR, ELISA, flow cytometry, and cell culture.

Publications

  • SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel
    • Authors: Yamashita, K., Sewastjanow-Silva, M., Yoshimura, K., …, Wang, L., Ajani, J.A.
    • Year: 2024
  • Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study
    • Authors: Sewastjanow-Silva, M., Xiao, L., Gonzalez, G.N., …, Ajani, J.A., Murphy, M.B.
    • Year: 2024
  • Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: Rogers, J.E., Yamashita, K., Sewastjanow-Silva, M., …, Waters, R.E., Ajani, J.
    • Year: 2023
    • Citations: 2
  • Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
    • Authors: Jin, J., Yoshimura, K., Sewastjanow-Silva, M., Song, S., Ajani, J.A.
    • Year: 2023
    • Citations: 12
  • Evolution of Immune and Stromal Cell States and Ecotypes during Gastric Adenocarcinoma Progression
    • Authors: Wang, R., Song, S., Qin, J., …, Ajani, J.A., Wang, L.
    • Year: 2023
    • Citations: 14
  • Epithelial SOX9 Drives Progression and Metastases of Gastric Adenocarcinoma by Promoting Immunosuppressive Tumour Microenvironment
    • Authors: Fan, Y., Li, Y., Yao, X., …, Ajani, J.A., Song, S.
    • Year: 2023
    • Citations: 24
  • A New Intronic Quantitative PCR Method Led to the Discovery of Transformation from Human Ascites to Murine Malignancy in a Mouse Model
    • Authors: Jin, J., Huo, L., Fan, Y., …, Song, S., Ajani, J.A.
    • Year: 2023
    • Citations: 1
  • Nivolumab Combination Therapy as First-Line Treatments for Unresectable, Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    • Authors: Rogers, J.E., Yamashita, K., Sewastjanow-Silva, M., …, Waters, R., Ajani, J.A.
    • Year: 2023
    • Citations: 1
  • GRK3 Is a Poor Prognosticator and Serves as a Therapeutic Target in Advanced Gastric Adenocarcinoma
    • Authors: Li, Y., Fan, Y., Xu, J., …, Song, S., Ajani, J.A.
    • Year: 2022
    • Citations: 3
  • Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors
    • Authors: Rogers, J.E., Yamashita, K., Sewastjanow Silva, M., Ajani, J.A.
    • Year: 2022